Conference Description

August 12, 2006
Hilton North Raleigh
3415 Wake Forest Road
Raleigh, NC 27609
919-878-4903

Tell a friend about this conference

Download the brochure for this conference

CME Credits: 7.0*

Nonrefundable registration fee: $0.

Target Audience: Physicians, Nurse Practitioners, and Physician Assistants.

Program Summary:
This program will provide Primary Care Physicians the opportunity to learn first hand from national thought leaders in their field. The goal is to provide a clearer understanding of several of the most common disease processes, in light of rapid scientific advances. By doing so, attendees will walk away with new insights and learn useful strategies to manage the challenges faced on a daily basis.

Learning Objectives:
At the conclusion of this program, participants should be able to:

1. more fully understand the origins of insulin resistance and type 2 Diabetes, and review studies of atherosclerosis prevention in patients with type 2 Diabetes
2. utilize appropriate first line therapies in the treatment of diabetes with the goal of targeting the various metabolic pathways in the management of hyperglycemia, thereby preventing development of complications
3. understand the role for insulin in patients with type 2 diabetes and develop strategies for initiating and adjusting therapy
4. evaluate and diagnose the anemia of chronic kidney disease, understand its impact on quality of life, and guide treatment decisions based on emerging data
5. identify surrogates of mortality in COPD and better utilize targeted patient interventions that improve patient’s outcomes
6. recognize the signs of Pulmonary Arterial Hypertension, guide appropriate evaluation and discuss the latest therapeutic options
7. utilize evolving data and novel therapies to understand and more effectively manage patients with chronic constipation
8. recognize the importance of achieving the recommended goal blood pressure rather than the superiority of a specific antihypertensive over another in improving patient outcome and understanding the importance of combination therapy to achieve effective blood pressure control

Agenda:

7:30-8:10 am		Registration, Continental Breakfast and Welcome
8:10-8:20		Welcome Remarks Gregg Sherman, MD
8:20-9:20		Insulin Resistance: From Impaired Glucose Tolerance to Type 2 Diabetes – Pathophysiologic Origins, Progression to Diabetes, Prevention of Atherosclerosis Patrick Boyle, MD
9:20-10:10		Treatment Early in the Time Course of Type 2 Diabetes Patrick Boyle, MD
10:10-10:30		Break
10:30-11:20		Beyond Oral Agents: Insulin Initiation and Management Cristina Mata, MD
11:20-12:10		Anemia in Chronic Kidney Disease: Clinical Implications and Treatment Options William McClellan, MD
12:10-1:00		Lunch
1:00-1:50		The Importance of Blood Pressure Control in The Management of Hypertension: Improving Outcomes in 2006 Jan Basile, MD
1:50-2:50		Classification, Evaluation, and Management of Pulmonary Arterial Hypertension C. William Hargett, MD
2:50-3:10		Break
3:10-4:00		Paving the way to Relief in Chronic Constipation Brooks D. Cash, MD, FACP
4:00-4:50		Evaluating disease severity in COPD: The Value of Patient Centered Outcomes Claudia Cote, MD
4:50-5:00		Conference Wrap Up Gregg Sherman, MD

Faculty:
Jan N. Basile, MD
Professor of Medicine in the Division of General Internal
Medicine/Geriatrics at the Medical University of South Carolina
Acting Director in Primary Care at
the Ralph H. Johnson VA Medical Center
Charleston, South Carolina

Patrick J. Boyle, MD
Professor of Medicine
University of New Mexico

Brooks D. Cash, MD, FACP
CDR, MC, USN
Chief, Gastroenterology Division and Colon Health Initiative
Associate Professor of Medicine
National Naval Medical Center

Claudia G. Cote, MD FCCP
Pulmonary and Critical Care Division
Bay Pines VA Medical Center

C. William Hargett, MD
Pulmonary Vascular Disease Center
Division of Pulmonary, Allergy, and Critical Care Medicine
Duke University Medical Center

Cristina Mata, MD
Medical Director of Diabetes Services
Holy Cross Hospital
Fort Lauderdale, FL

William McClellan, Jr., MD, MPH
Professor, Department of Medicine, Division of Renal Medicine
Emory University School of Medicine

Program Chair: Gregg Sherman, MD

Activity Director: Alan Goodstat, LCSW

*Continuing Education Information
Application for CME credit has been filed with the American Academy of Family Physicians. Determination of credit is pending.

This activity has been planned and implemented in accordance with the Essentials and Standards of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of the University of Massachusetts Medical School (UMMS) and the National Association for Continuing Education. UMMS is accredited by ACCME to provide continuing medical education for physicians. UMMS designates this continuing medical education activity for 7 credit hours in Category I toward the Physicians Recognition Award of the American Medical Association. Each physician should claim only those hours of credit that he/she actually spent in the educational activity.

Under the auspices of the University of Massachusetts Medical School Office of Continuing Education this offering meets the requirements for 8.4 contact hours, as specified by the Massachusetts Board of Registration in Nursing (244-CMR 5.04). Each nurse should claim only those hours of credit that he/she actually spend in the educational activity.

This program was supported through educational grants from the following companies: Actelion, Amgen, Boehringer Ingelheim, Bristol-Myers Squibb, Novo nordisk, Pfizer, sanofi-aventis, Takeda, Wyeth.